In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen

  1. J.-P. Cazenave*,
  2. B. Aleil,
  3. M.-L. Wiesel,
  4. M. Laforêt,
  5. H. Isola

Article first published online: 7 APR 2004

DOI: 10.1111/j.0042-9007.2004.00417.x

Issue

Vox Sanguinis

Vox Sanguinis

Volume 86, Issue 3, pages 201–202, April 2004

Additional Information

How to Cite

Cazenave, J.-P., Aleil, B., Wiesel, M.-L., Laforêt, M. and Isola, H. (2004), In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen. Vox Sanguinis, 86: 201–202. doi: 10.1111/j.0042-9007.2004.00417.x

Author Information

  1. Etablissement Français du Sang-Alsace, Strasbourg, France

*J.-P. Cazenave Etablissement Français du Sang-Alsace 10 rue Spielmann BP 36 67065 Strasbourg cedex France E-mail: jeanpierre.cazenave@efs-alsace.fr

Publication History

  1. Issue published online: 7 APR 2004
  2. Article first published online: 7 APR 2004
  3. Received: 2 February 2004, accepted 4 February 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (61K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Diquattro, G. Francisci, R. Bonaccorso, A. M. Tagliavia, M. Marcatti, B. Palma, R. Agliastro, Evaluation of amotosalem treated platelets over 7 days of storage with an automated cytometry assay panel, International Journal of Laboratory Hematology, 2013, 35, 3
    Direct Link:
  2. 2
    Marie E. Tauszig, Susanne M. Picker, Birgit S. Gathof, Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction, Transfusion and Apheresis Science, 2012, 46, 1, 33

    CrossRef

  3. You have free access to this content3
    Jean-Pierre Cazenave, Hervé Isola, Chantal Waller, Isabelle Mendel, Daniel Kientz, Michel Laforêt, Jean-Pierre Raidot, Gérard Kandel, Marie-Louise Wiesel, Laurence Corash, Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period, Transfusion, 2011, 51, 3
    Direct Link:
  4. 4
    C. Naegelen, H. Isola, D. Dernis, J.-P. Maurel, R. Tardivel, S. Bois, C. Vignoli, J.-P. Cazenave, Évolution des techniques de préparation des produits sanguins labiles (PSL) : inactivation des pathogènes dans les PSL, Transfusion Clinique et Biologique, 2009, 16, 2, 179

    CrossRef

  5. 5
    Torunn O. Apelseth, Øystein Bruserud, Tore Wentzel-Larsen, Anne M. Bakken, Solfrid Bjørsvik, Tor Hervig, In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage, Transfusion, 2007, 47, 4
    Direct Link:
  6. 6
    Torunn O. Apelseth, Tor A. Hervig, Tore Wentzel-Larsen, Øystein Bruserud, Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage, Transfusion, 2006, 46, 5
    Direct Link:
  7. 7
    J.P.R. Pelletier, S. Transue, E.L. Snyder, Pathogen inactivation techniques, Best Practice & Research Clinical Haematology, 2006, 19, 1, 205

    CrossRef

  8. 8
    P. Morel, M. Deschaseaux, C. Naegelen, L. Bardiaux, M.F. Leconte des Floris, F. Pouthier, De la détection bactérienne à l'inactivation des pathogènes, Transfusion Clinique et Biologique, 2005, 12, 2, 142

    CrossRef

View Full Article (HTML) Get PDF (61K)